日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment

对接受C5抑制剂治疗后仍存在残余贫血的阵发性睡眠性血红蛋白尿患者,比较iptacopan与pegcetacoplan的间接治疗效果

Kulasekararaj, Austin; Scheinberg, Phillip; Balp, Maria-Magdalena; Somenzi, Olivier; Wiyani, Anggie; Snellman, Josefin; Walsh, Sarah; Pannagl, Katharina; Steenkamp, Jason; de Latour, Régis Peffault

Clinical Profile, Humanistic and Economic Burden of Paroxysmal Nocturnal Hemoglobinuria in Patients Treated With C5 Inhibitors

C5抑制剂治疗阵发性睡眠性血红蛋白尿患者的临床特征、人文和经济负担

Gandhi, Shreyans; Radsak, Markus P; Ueda, Yasutaka; Balp, Maria-Magdalena; Wiyani, Anggie; Somenzi, Olivier; Snellman, Josefin; Taylor, Yasmin; Simons, Alice; Panse, Jens

How have Economic Evaluations in Relapsing Multiple Sclerosis Evolved Over Time? A Systematic Literature Review

复发型多发性硬化症的经济评价是如何随着时间推移而演变的?一项系统性文献综述

Wiyani, Anggie; Badgujar, Lohit; Khurana, Vivek; Adlard, Nicholas